Down-regulation of microsomal prostaglandin e2 synthase-1 in adipose tissue by high-fat feeding

Obesity

Volumn 15, Issue 1, 2007, Pages 60-68

  Hétu, Pierre Olivier ^b   Riendeau, Denis ^a  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^b NONE

Author keywords

Lipolysis; Prostaglandins; Subcutaneous adipose tissue; Visceral fat

Indexed keywords

ISOMERASE; PROSTAGLANDIN E SYNTHASE;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL; ARTICLE; C57BL MOUSE; CELL STRAIN 3T3; DOWN REGULATION; ENZYMOLOGY; HUMAN; MALE; METABOLISM; MICROSOME; MOUSE; PHYSIOLOGY; RANDOMIZATION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; BLOTTING, WESTERN; DOWN-REGULATION; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MICE; MICE, INBRED C57BL; MICROSOMES; RANDOM ALLOCATION;

ANIMALIA; MUS;

EID: 33846876327     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.514     Document Type: Article

References (52)

1. Weisberg SP, McCann D, Desai M, Rosen baum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112:1796808.
2. Clement K, Viguerie N, Poitou C, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J. 2004;18:1657-69.
3. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46:2347-55.
4. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003; 112:1821-30.
5. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans. 2005;33:1078-81.
6. Bouloumie A, Curat CA, Sengenes C, Lolmede K, Miranville A, Busse R. Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care. 2005; 8:347-54.
7. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 1997;389:610-4.
8. Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science. 2001;293:1673-7.
9. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and sub-cutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004; 145:2273-82.
10. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409-15.
11. Yudkin JS. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord. 2003;27(Suppl 3):S25-8.
12. Steinberg D, Vaughan M, Nestel PJ, Strand O, Bergstroem S. Effects of the prostaglandins on hormone-induced mobilization of free fatty acids. J Clin Invest. 1964;43:1533-40.
13. 2 on adenylate cyclase activity and lipolysis in human adipose tissue. Int J Obes Relat Metab Disord. 1981;5:659-63.
14. Richelsen B. Release and effects of prostaglandins in adipose tissue. Prostaglandins Leukot Essent Fatty Acids. 1992;47: 171-82.
15. 2 and prostacyclin in rat adipose tissue. Diabetes. 1992;41:927-35.
16. 2 in perifused rat adipocytes. Endocrinology. 1987; 121: 1221-6.
17. 2. Metabolism. 1991;40:990-6.
18. 2 and its synthetic analogue sulprostrone. Prostaglandins Leukot Med. 1982;8: 525-9.
19. Strong P, Coleman RA, Humphrey PP. Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: probable involvement of EP3 receptors. Prostaglandins. 1992;43:559-66.
20. Tsuboi H, Sugimoto Y, Kainoh T, Ichikawa A. Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation. Biochem Biophys Res Commun. 2004;322: 1066-72.
21. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294:1871-5.
22. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-l and -2. J Biol Chem. 1996;271:33157-60.
23. 2 production in the rat adjuvant-induced arthritis model. J Immunol. 2003;170:4738-44.
24. Trebino CE, Stock JL, Gibbons CP, et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA. 2003;100: 9044-9.
25. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999;79: 1193-226.
26. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA. 1999; 96:7220-5.
27. Quellet M, Falgueyret JP, Ear PH, et al. Purification and characterization of recombinant microsomal prostaglandin E synthase-1. Protein Expr Purif. 2002;26:489-95.
28. Tanikawa N, Ohmiya Y, Ohkubo H, et al. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun. 2002; 291:884-9.
29. 2 biosynthesis. J Biol Chem. 2000; 275:32775-82.
30. 2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem. 2003;278:37937-47.
31. Fahmi H. mPGES-1 as a novel target for arthritis. Curr Opin Rheumatol. 2004;16:623-7.
32. Gaskins HR, Hausman DB, Martin RJ, Hausman GJ. Evidence for abnormal prostaglandin synthesis in obese Zucker rat adipose cell cultures. J Nutr. 1989;119:458-62.
33. 2 synthase-1. J Biol Chem. 2004;279:24866-72.
34. 2 production and alters the gastric prostanoid profile. J Biol Chem. 2004;279:23229-37.
35. Soni KG, Lehner R, Metalnikov P, et al. Carboxylesterase 3 (EC 3.1.1.1) is a major adipocyte lipase. J Biol Chem. 2004; 279:40683-9.
36. Buettner R, Parhofer KG, Woenckhaus M, et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol. 2006;36:485-501.
37. Mancini JA, Blood K, Guay J, et al. Cloning, expression, and up-regulation of inducible rat prostaglandin e synthase during lipopolysaccharide-induced pyresis and adjuvantinduced arthritis. J Biol Chem. 2001;276:4469-75.
38. 2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem. 2000;275:32783-92.
39. Xie Y, Kang X, Ackerman WE, et al. Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes Obes Metab. 2006;8:83-93.
40. 4. Eur J Biochem. 2000;267:6428-34.
41. Forsberg L, Leeb L, Thoren S, Morgenstern R, Jakobsson P. Human glutathione dependent prostaglandin E synthase: gene structure and regulation. FEBS Lett. 2000;471: 78-82.
42. Ekstrom L, Lyrenas L, Jakobsson PJ, Morgenstern R, Keiner MJ. Basal expression of the human MAPEG members microsomal glutathione transferase 1 and prostaglandin E synthase genes is mediated by Spl and Sp3. Biochim Biophys Acta. 2003;1627:79-84.
43. Kubota K, Kubota T, Kamei D, et al. Change in prostaglandin E synthases (PGESs) in microsomal PGES-1 knockout mice in a preterm delivery model. J Endocrinol. 2005; 187: 339-45.
44. Shaw JE, Ramwell PW. Release of prostaglandin from rat epididymal fat pad on nervous and hormonal stimulation. J Biol Chem. 1968;243:1498-503.
45. Illiano G, Cuatrecasas P. Endogenous prostaglandins modulate lipolytic processes in adipose tissue. Nat New Biol. 1971;234:72-4.
46. Daiton C, Hope HR. Inability of prostaglandin synthesis inhibitors to affect adipose tissue lipolysis. Prostaglandins. 1973;4:641-51.
47. Fain JN, Psychoyos S, Czernik AJ, Frost S, Cash WD. Indomethacin, lipolysis, and cyclic AMP accumulation in white fat cells. Endocrinology. 1973;93:632-9.
48. Casimir DA, Miller CW, Ntambi JM. Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells. Differentiation. 1996;60:203-10.
49. Gaillard D, Negrel R, Lagarde M, Ailhaud G. Requirement and role of arachidonic acid in the differentiation of preadipose cells. Biochem J. 1989;257:389-97.
50. Negrel R, Gaillard D, Ailhaud G. Prostacyclin as a potent effector of adipose-cell differentiation. Biochem J. 1989;257: 399-405.
51. 2 alpha. Biochim Biophys Acta. 1991;1091: 364-9.
52. Petersen RK, Jorgensen C, Rustan AC, et al. Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases. J Lipid Res. 2003;44:2320-30.